Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 03, 2020

SELL
$74.18 - $108.93 $296,720 - $435,720
-4,000 Closed
0 $0
Q4 2019

Jan 27, 2020

BUY
$73.04 - $95.72 $292,160 - $382,880
4,000 New
4,000 $349,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track K.J. Harrison & Partners Inc Portfolio

Follow K.J. Harrison & Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.